Compounds > phenytoin

phenytoin and selegiline

phenytoin has been researched along with selegiline in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (8.33)	18.2507
2000's	4 (33.33)	29.6817
2010's	7 (58.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Gozalbes, R; Pineda-Lucena, A	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Keppel Hesselink, JM	1
Mannerström, M; Tähti, H	1
Kato, S; Kobayashi, T; Saito, N; Shioda, K; Suda, S	1
Ayyannan, SR; Tripathi, RK	1

Reviews

1 review(s) available for phenytoin and selegiline

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

11 other study(ies) available for phenytoin and selegiline

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
QSAR-based solubility model for drug-like compounds. Bioorganic & medicinal chemistry, 2010, Oct-01, Volume: 18, Issue:19 Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water	2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
['Smart drugs' enticements on the Internet]. Nederlands tijdschrift voor geneeskunde, 1998, Apr-25, Volume: 142, Issue:17 Topics: Advertising; Computer Communication Networks; Human Growth Hormone; Humans; Illicit Drugs; Nonprescription Drugs; Nootropic Agents; Phenytoin; Selegiline; Self Medication; Substance-Related Disorders	1998
Modulation of glucose uptake in glial and neuronal cell lines by selected neurological drugs. Toxicology letters, 2004, Jun-15, Volume: 151, Issue:1 Topics: 3-O-Methylglucose; Amitriptyline; Anticonvulsants; Antidepressive Agents; Antimanic Agents; Carbamazepine; Cell Line, Tumor; Humans; Immunohistochemistry; Monoamine Oxidase Inhibitors; Monosaccharide Transport Proteins; Neuroglia; Neurons; Phenytoin; Selegiline	2004
Pharmacoresistant convulsions and visual hallucinations around two weeks after selegiline overdose: a case report. Pharmacopsychiatry, 2011, Volume: 44, Issue:7 Topics: Anticonvulsants; Bipolar Disorder; Coma; Diazepam; Drug Overdose; Drug Resistance; Hallucinations; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Phenytoin; Seizures; Selegiline; Suicide, Attempted	2011
Design, Synthesis, and Evaluation of 2-Amino-6-nitrobenzothiazole-Derived Hydrazones as MAO Inhibitors: Role of the Methylene Spacer Group. ChemMedChem, 2016, 07-19, Volume: 11, Issue:14 Topics: Animals; Antidepressive Agents; Benzothiazoles; Brain; Catalytic Domain; Clorgyline; Drug Design; Hydrazones; Hydrogen Bonding; Kinetics; Ligands; Molecular Docking Simulation; Monoamine Oxidase Inhibitors; Phenytoin; Rats; Selegiline; Structure-Activity Relationship	2016